TITLE

An investigation of WNT pathway activation and association with survival in central nervous system primitive neuroectodermal tumours (CNS PNET)

AUTHOR(S)
Rogers, H. A.; Miller, S.; Lowe, J.; Brundler, M.-A.; Coyle, B.; Grundy, R. G.
PUB. DATE
April 2009
SOURCE
British Journal of Cancer;4/21/2009, Vol. 100 Issue 8, p1292
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Central nervous system primitive neuroectodermal tumours (CNS PNET) are high-grade, predominantly paediatric, brain tumours. Previously they have been grouped with medulloblastomas owing to their histological similarities. The WNT/β-catenin pathway has been implicated in many tumour types, including medulloblastoma. On pathway activation β-catenin (CTNNB1) translocates to the nucleus, where it induces transcription of target genes. It is commonly upregulated in tumours by mutations in the key pathway components APC and CTNNB1. WNT/β-catenin pathway status was investigated by immunohistochemical analysis of CTNNB1 and the pathway target cyclin D1 (CCND1) in 49 CNS PNETs and 46 medulloblastomas. The mutational status of APC and CTNNB1 (β-catenin) was investigated in 33 CNS PNETs and 22 medulloblastomas. CTNNB1 nuclear localisation was seen in 36% of CNS PNETs and 27% of medulloblastomas. A significant correlation was found between CTNNB1 nuclear localisation and CCND1 levels. Mutations in CTNNB1 were identified in 4% of CNS PNETs and 20% of medulloblastomas. No mutations were identified in APC. A potential link between the level of nuclear staining and a better prognosis was identified in the CNS PNETs, suggesting that the extent of pathway activation is linked to outcome. The results suggest that the WNT/β-catenin pathway plays an important role in the pathogenesis of CNS PNETs. However, activation is not caused by mutations in CTNNB1 or APC in the majority of CNS PNET cases.British Journal of Cancer (2009) 100, 1292–1302; doi:10.1038/sj.bjc.6604979 www.bjcancer.com Published online 17 March 2009
ACCESSION #
37591424

 

Related Articles

  • FABP4 is a candidate marker of cerebellar liponeurocytomas. Anghileri, Elena; Eoli, Marica; Paterra, Rosina; Ferroli, Paolo; Pollo, Bianca; Cuccarini, Valeria; Maderna, Emanuela; Tringali, Giovanni; Saini, Marco; Salsano, Ettore; Finocchiaro, Gaetano // Journal of Neuro-Oncology;Jul2012, Vol. 108 Issue 3, p513 

    Cerebellar liponeurocytoma (cLPN) is a very rare central nervous system (CNS) tumour recently recognized as a clinical and pathological entity distinct from medulloblastoma (MB), and included in the WHO classification of CNS tumours under the heading 'glioneuronal tumours'. cLPN typically...

  • A Regulatory Loop Involving PAX6, MITF, and WNT Signaling Controls Retinal Pigment Epithelium Development. Bharti, Kapil; Gasper, Melanie; Jingxing Ou; Brucato, Martha; Clore-Gronenborn, Katharina; Pickel, James; Arnheiter, Heinz // PLoS Genetics;Jul2012, Vol. 8 Issue 7, Special section p1 

    The separation of the optic neuroepithelium into future retina and retinal pigment epithelium (RPE) is a critical event in early eye development in vertebrates. Here we show in mice that the transcription factor PAX6, well-known for its retina- promoting activity, also plays a crucial role in...

  • Medulloblastoma: a potpourri of distinct entities. Pfister, Stefan // Acta Neuropathologica;Apr2012, Vol. 123 Issue 4, p463 

    An introduction is presented in which the author discusses various reports within the issue on topics including the classification of World Health Organization (WHO) to central nervous system (CNS) tumors, medulloblastoma gene expression, and sonic hedgehog (SHH)-driven medulloblastoma.

  • A distinct pattern of Olig2-positive cellular distribution in papillary glioneuronal tumors: a manifestation of the oligodendroglial phenotype? Tanaka, Yuko; Yokoo, Hideaki; Komori, Takashi; Makita, Yoshihisa; Ishizawa, Takashi; Hirose, Takanori; Ebato, Michimasa; Shibahara, Junji; Tsukayama, Choutatsu; Shibuya, Makoto; Nakazato, Yoichi // Acta Neuropathologica;Jul2005, Vol. 110 Issue 1, p39 

    Mixed neuronal-glial tumors of the central nervous system display a wide spectrum of differentiation. Among them, the papillary glioneuronal tumor (PGNT) is characterized by pseudopapillary structures composed of astroglial cells covering hyalinized vessels, and by neurocytic, ganglioid and...

  • Atypical Teratoid/Rhabdoid Tumor: An Unusual Variant of a Rare Entity. Jaggon, Jacqueline R.; Bishop, Karen L.; Pedican, Mandi C.; Halliday, W.; Melbourne-Chambers, Roxanne; Tapper, Judy M. // Internet Journal of Oncology;2009, Vol. 6 Issue 2, p2 

    Atypical teratoid/rhabdoid tumors (AT/RTs) of the central nervous system (CNS) are distinctive, malignant neoplasms of uncertain histogenesis. They are thought to be embryonal and are usually composed of varying amounts of rhabdoid-type cells, small primitive neuroepithelial cells, epithelial...

  • H3F3A K27M Mutation in Pediatric CNS Tumors. Gielen, Gerrit H.; Gessi, Marco; Hammes, Jennifer; Kramm, Christof M.; Waha, Andreas; Pietsch, Torsten // American Journal of Clinical Pathology;Mar2013, Vol. 139 Issue 3, p345 

    Brain tumors are one of the most common childhood malignancies. Diffuse high-grade gliomas represent approximately 10% of pediatric brain tumors. Exon sequencing has identified a mutation in K27M of the histone H3.3 gene (H3F3A K27M and G34R/V) in about 20% of pediatric glioblastomas, but it...

  • Molecular functions of the TLE tetramerization domain in Wnt target gene repression. Chodaparambil, Jayanth V; Pate, Kira T; Hepler, Margretta R D; Tsai, Becky P; Muthurajan, Uma M; Luger, Karolin; Waterman, Marian L; Weis, William I // EMBO Journal;4/1/2014, Vol. 33 Issue 7, p719 

    Wnt signaling activates target genes by promoting association of the co-activator β-catenin with TCF/ LEF transcription factors. In the absence of β-catenin, target genes are silenced by TCF-mediated recruitment of TLE/Groucho proteins, but the molecular basis for TLE/ TCF-dependent...

  • Stratification of medulloblastoma on the basis of histopathological grading. Giangaspero, Felice; Wellek, Stefan; Masuoka, Jun; Gessi, Marco; Kleihues, Paul; Ohgaki, Hiroko // Acta Neuropathologica;Jul2006, Vol. 112 Issue 1, p5 

    Medulloblastoma (WHO grade IV) is an embryonal tumour of the cerebellum and the most common malignant central nervous system tumour in children. Despite significant advances in treatment, 5-year survival rates are still less than 70%, suggesting the presence of subgroups with different response...

  • Mass biological profiling of cns tumours: Is it possible in india? Ray, A.; Buffet, E.; Rutka, J. T.; Hawkins, C. // Journal of Pediatric Neurosciences;Jul-Dec2007, Vol. 2 Issue 2, p102 

    INTRODUCTION: Biological profiling of tumours to predict outcome is gaining increasing popularity in the western world. The paucity of equipment and the prohibitive costs have meant that such profiling has not been universally popular especially in the developing world. This paper tries to...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics